PAPER Abisambra JF, Scheff S
SEARCH RESULTS
331009 RESULTS
PAPER Saharan S, Mandal PK
The emerging role of glutathione in Alzheimer's disease.
J Alzheimers Dis. 2014;40(3):519-29. PubMed: 24496077PAPER Buckley RF, Saling MM, Irish M, Ames D, Rowe CC, Lautenschlager NT, Maruff P, Macaulay SL, Martins RN, Masters CL, Rainey-Smith SR, Rembach A, Savage G, Szoeke C, Ellis KA
Personal memory function in mild cognitive impairment and subjective memory complaints: results from the Australian Imaging, Biomarkers, and Lifestyle (AIBL) Study of Ageing.
J Alzheimers Dis. 2014;40(3):551-61. PubMed: 24496075PAPER Bedse G, Romano A, Cianci S, Lavecchia AM, Lorenzo P, Elphick MR, Laferla FM, Vendemiale G, Grillo C, Altieri F, Cassano T, Gaetani S
Altered expression of the CB1 cannabinoid receptor in the triple transgenic mouse model of Alzheimer's disease.
J Alzheimers Dis. 2014;40(3):701-12. PubMed: 24496074PAPER Cunningham RL, Singh M, O'Bryant SE, Hall JR, Barber RC
Oxidative stress, testosterone, and cognition among Caucasian and Mexican-American men with and without Alzheimer's disease.
J Alzheimers Dis. 2014;40(3):563-73. PubMed: 24496073PAPER O'Caoimh R, Healy L, Gao Y, Svendrovski A, Kerins DM, Eustace J, Kehoe PG, Guyatt G, Molloy DW
Effects of centrally acting angiotensin converting enzyme inhibitors on functional decline in patients with Alzheimer's disease.
J Alzheimers Dis. 2014;40(3):595-603. PubMed: 24496072PAPER Steenland K, Zhao L, Goldstein F, Cellar J, Lah J
Biomarkers for predicting cognitive decline in those with normal cognition.
J Alzheimers Dis. 2014;40(3):587-94. PubMed: 24496071PAPER Sui X, Ren X, Huang P, Li S, Ma Q, Ying M, Ni J, Liu J, Yang X
Proteomic analysis of serum proteins in triple transgenic Alzheimer's disease mice: implications for identifying biomarkers for use to screen potential candidate therapeutic drugs for early Alzheimer's disease.
J Alzheimers Dis. 2014;40(3):575-86. PubMed: 24496070PAPER Ruiz A, Heilmann S, Becker T, Hernández I, Wagner H, Thelen M, Mauleón A, Rosende-Roca M, Bellenguez C, Bis JC, Harold D, Gerrish A, Sims R, Sotolongo-Grau O, Espinosa A, Alegret M, Arrieta JL, Lacour A, Leber M, Becker J, Lafuente A, Ruiz S, Vargas L, Rodríguez O, Ortega G, Dominguez MA, IGAP, Mayeux R, Haines JL, Pericak-Vance MA, Farrer LA, Schellenberg GD, Chouraki V, Launer LJ, van Duijn C, Seshadri S, Antúnez C, Breteler MM, Serrano-Ríos M, Jessen F, Tárraga L, Nöthen MM, Maier W, Boada M, Ramírez A
Follow-up of loci from the International Genomics of Alzheimer's Disease Project identifies TRIP4 as a novel susceptibility gene.
Transl Psychiatry. 2014 Feb 4;4:e358. PubMed: 24495969PAPER Cornejo-Olivas MR, Yu CE, Mazzetti P, Mata IF, Meza M, Lindo-Samanamud S, Leverenz JB, Bird TD
Clinical and molecular studies reveal a PSEN1 mutation (L153V) in a Peruvian family with early-onset Alzheimer's disease.
Neurosci Lett. 2014 Mar 20;563:140-3. Epub 2014 Feb 2 PubMed: 24495933PAPER Behrman S, Chouliaras L, Ebmeier KP
Considering the senses in the diagnosis and management of dementia.
Maturitas. 2014 Apr;77(4):305-10. Epub 2014 Jan 18 PubMed: 24495787PAPER Nygaard HB, van Dyck CH, Strittmatter SM
Fyn kinase inhibition as a novel therapy for Alzheimer's disease.
Alzheimers Res Ther. 2014;6(1):8. Epub 2014 Feb 5 PubMed: 24495408PAPER Camargos EF, Louzada LL, Quintas JL, Naves JO, Louzada FM, Nóbrega OT
Trazodone Improves Sleep Parameters in Alzheimer Disease Patients: A Randomized, Double-Blind, and Placebo-Controlled Study.
Am J Geriatr Psychiatry. 2014 Jan 4; PubMed: 24495406PAPER Yi D, Lee DY, Sohn BK, Choe YM, Seo EH, Byun MS, Woo JI
Beta-Amyloid Associated Differential Effects of APOE ε4 on Brain Metabolism in Cognitively Normal Elderly.
Am J Geriatr Psychiatry. 2014 Jan 4; PubMed: 24495404PAPER Barnes DE, Cenzer IS, Yaffe K, Ritchie CS, Lee SJ, Alzheimer's Disease Neuroimaging Initiative
A point-based tool to predict conversion from mild cognitive impairment to probable Alzheimer's disease.
Alzheimers Dement. 2014 Feb 1; PubMed: 24495339Current Filters
No filters selected